featured
Time for a Cannabis Reboot: Local Roots, Fair Markets, Real Change
Published
5 hours agoon
Written by Shaleen Title and Damian Fagon
Federal cannabis bills are not coming to save us. It’s October 2025, and the corporate-led strategy that has dominated the movement is dead. The same bills get introduced over and over, and like zombies, we deliver the same recycled responses, fight the same identical fights, and make no progress. We are no closer to federal legalization than we were five years ago. The attempted corporate takeover has clearly failed, and we’re still pretending that doing the exact same thing will yield a different result.
The cannabis policy movement needs a reboot. We are ready to pull the plug on this failed approach and start building the cannabis market we actually want instead, and we hope you will join us. It’s time for a complete overhaul, with a new strategy that puts local communities and fair markets at the center.
Wall Street Weed still frames this as a fairy tale in which they are the heroes, fighting valiantly for incremental wins while moral purists hold them back. But the truth is simpler: no one is holding them back. Despite all the money and lobbying, their strategy has failed.
The movement tried selling out to publicly traded cannabis companies – the most ambitious among us even selling out to Big Tobacco – and we remain stalled. Their lobbyists promised momentum and results but delivered nothing. None of their preferred bills passed, and none of their stated goals were met.
The good news is that we can change course by putting people over profits and building local power to bring real change. But first, we have to name the zombie ideas that keep staggering through every legislative session, devouring resources and delivering nothing.
First: “Federal legalization now; we’ll work out the details later.”
That argument made sense when we didn’t yet know what legalization looked like. But we do now. The details are the policy. Most people in the U.S. have access to dispensaries. They don’t particularly care about banking access and tax rates. Instead, we need to tell a clear story supporting a specific federal cannabis package with guardrails that protect all of us – consumers, workers, small businesses, and yes, communities harmed by prohibition.
Thanks to the selfless people who began this movement, the reform of federal cannabis laws remains a massively popular issue across the political spectrum. Our research shows that a majority of Americans believe legalization should benefit people who use marijuana as medicine, people who use marijuana for pleasure, people who have been harmed by past enforcement, workers, everyday people, locally owned businesses, and small businesses. A majority does not say the same for pharma, alcohol, tobacco, or large corporations. It’s time to start working toward that goal.
Second: “The market will figure it out”
This is not the 1980s. Relying on the so-called “free market” to equitably distribute value back to workers, small businesses, and consumers is a joke, and we all know it. Markets are intentionally constructed through policy and politics, not magic. Corporate free-for-alls don’t distribute wealth fairly; they concentrate it at the top. We can have markets that reward labor and local small businesses, but only if we build them intentionally.
That means structuring markets that separate growing, processing, and retail operations so no company can dominate every stage of the supply chain. It means explicitly limiting ownership concentration, protecting local programs that favor local businesses, and creating real protections for workers. We already have a blueprint from states that have created relatively fair and competitive cannabis markets, far more friendly to small businesses than comparable industries. These aren’t accidents – they’re the result of intentional policy design, and they can be replicated at the federal level.
Third: “Any marijuana bill is better than no marijuana bill”
No, it isn’t. Marijuana bills are not universally good. It will take an adjustment, but our movement has to understand and accept that some bills would have genuinely harmful consequences. In our view, a federal legalization bill that hands control of the market to giant conglomerates and continues criminalization in the American South is worse than the status quo. Passing the wrong bill could cement monopoly power for a generation.
And look, this would be a fair debate if corporate-backed bills were actually passing. But they’re not. So why are we tirelessly supporting their failed bills with our limited time, energy, and resources every session? Do you really think they’ll remember and reward us if they ever get their tax cut or buyout?
Let’s have some self-respect. Any bill without a plan to prevent monopolization should be a nonstarter. Let’s stop conflating justice with profits. Let’s stop pretending that incremental “progress” that only benefits large corporations is progress at all. Because states really are making some progress – they are clearing convictions, funding equity programs, and giving new entrepreneurs a shot. We need federal policy that protects and enhances these efforts, not erases them.
Looking Forward
For those of us who’ve been in this fight since before 2012, it’s time for clear-eyed assessment. We helped pass and implement one of the most significant policy changes in modern U.S. history, and that’s worth celebrating. But the playbook we built belonged to a different era, a time when wealth was less concentrated and corporate responsibility still meant something. Today’s inequality demands new tools. The old libertarian formula doesn’t just fail; it fuels the very harms we set out to repair.
The next phase belongs to a multicultural movement that understands post-legalization realities and sees how monopolies and regulatory capture threaten both justice and opportunity. Those of us who shaped the early reforms can still play a role as mentors helping this new generation take cannabis policy where it needs to go.
This new generation already has its north star: people first, profit last. As Kassandra Frederique of the Drug Policy Alliance reminds us, “The drug can’t have more rights than the people do.” That principle is not rhetorical; it’s the heart of this fight. If we are still obsessing over banking access and tax deductions while consumers are being criminalized again, we no longer have a movement. Brownie Mary and the AIDS activists who built this fight understood that cannabis was always about the health, safety and dignity of people.
And the people are still with us. Seventy percent of Americans support some form of legalization, but they are not asking for more corporate consolidation or Wall Street control. The cannabis industry doesn’t have to become yet another monopoly that drains more than it provides. But changing that outcome means replacing the old rules with new ones built around fairness, transparency, and justice.
The next era of cannabis reform will not be decided in Congress or corporate boardrooms. It will be built, once again, by people.
Shaleen Title and Damian Fagon are former cannabis regulators with Parabola Center for Law and Policy. Register for Parabola Center’s annual People Over Profits event in NYC this Saturday at parabolacenter.com/crashcourse.
This article is from an external, unpaid contributor. It does not represent High Times’ reporting and has not been edited for content or accuracy.
Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
You may like
-
Ohio House Passes Cannabis, Hemp Bill Resulting From ‘Venn Diagram From Hell’
-
What To Know About Cannabis And A Brain Aneurysm
-
MariMed to Expand Brand Distribution to New York
-
Ohio Health Agency Grants $400,000 To Fund Psychedelics Education And Training For First Responders, Doctors And More
-
Curio Wellness Acquires 4 Greenlight Dispensaries in Missouri
-
The best places to be high in Seattle
featured
Ohio House Passes Cannabis, Hemp Bill Resulting From ‘Venn Diagram From Hell’
Published
2 hours agoon
October 23, 2025
Ohio House lawmakers passed the 18th version of a bill on Oct. 22 that aims to alter the state’s adult-use cannabis laws that voters approved in 2023, while also creating a tightly defined regulatory framework for hemp products.
The 228-page legislation, Substitute Senate Bill 56, preserves many aspects of the voter-approved initiative, such as home grows (six per adult or 12 per household), sharing between adults 21 and older, and allocating 36% of cannabis excise tax revenues to local municipalities that host dispensaries.
However, the bill would prohibit public consumption at places like music concerts and bar patios, and those caught with cannabis purchased outside the state would be criminalized. No other state where cannabis is legal imposes such restrictions on out-of-state purchases, according to cannabis advocacy group NORML.
In addition, while adults could continue to home cultivate cannabis under the legislation, they’d be restricted to harvesting more than 2.5 ounces of flower, or roughly one plant, with a felony penalty for those who grow more than the number of plants allowed. Also, the bill intends to place a 35% THC cap on flower and a 70% THC cap on extracts for both medical and adult-use cannabis.
“This isn’t what Ohioans voted for, and the fact that this bill is being rushed through the Legislature, with almost no opportunity for public comment, indicates that lawmakers know they are undermining the will of the voters,” NORML Political Director Morgan Fox said in a public statement. “Regardless of where one stands on cannabis issues, everyone should be outraged at this.”
The substitute bill found bipartisan House support in an 87-8 vote on Oct. 22.
Rep. Brian Stewart, R-Ashville, who carried Sub. S.B. 56 in the House, said Wednesday on the chamber floor that the bill “preserves all of the core aspects” of what voters passed two years ago, including access to tested and regulated products from licensed dispensaries.
Stewart also argued that the Legislature has to act to preserve the 36% tax revenue fund for host communities after the Ohio Department of Taxation flagged language in the voter-approved initiative, suggesting that the language failed to properly appropriate the money.
“It was always going to require legislation in this chamber,” he said.
The substitute bill also intends to establish a legal pathway for licensed “hemp dispensaries” to sell regulated and tested intoxicating hemp products, defined as containing more than 0.5 milligrams of delta-9 THC per serving or 2 milligrams per package, or more than 0.5 milligrams of total non-delta-9 THC per package. These sales would be limited to those 21 and older. Those who sell intoxicating hemp products to those under 21 would be guilty of a misdemeanor on the first offense and a felony on a subsequent offense.
Meanwhile, cannabinoid hemp beverages would be defined and regulated differently with a $1.20-per-gallon excise tax (more on this later).
Stewart said provisions included in the 18th version of the substitute bill resulted from a “Venn diagram from hell” that attempted to balance individual liberties, consumer safety, the financial well-being of local communities, and the “need to protect the health and safety” of Ohio children.
“If you’re reading through it and you’re saying, ‘Rep. Stewart, I don’t like Section X, I don’t like Section Y,’ please know you’re in good company. I don’t either,” he said. “This is not the bill that I originally introduced. It’s not the bill that Representative [Tex] Fischer originally introduced. But it is a carefully crafted compromise that makes Ohio better.”
While the Senate passed its version of the legislation in February, cannabis advocacy groups like the Marijuana Policy Project applauded the House Judiciary Committee for sitting on the legislation for nearly eight months as a means to prevent recriminalization measures “pushed by the Senate.”
However, many House members said during this week’s floor debate that Gov. Mike DeWine’s executive order issued Oct. 8 – one that attempts to shut down hemp-derived cannabinoid product sales and initiate emergency rulemaking – spurred lawmakers to go back to the drawing board for a legislative fix.
DeWine showcased various intoxicating hemp products in packaging that mimicked popular candies, like Nerds, Sour Patch Kids and Gushers, during his Oct. 8 press conference.
After lawmakers were at an impasse, DeWine’s executive order represented a turning point on Sub. S.B. 56, Rep. Tex Fischer, R-Boardman, said before Wednesday’s floor vote.
“I think we all had an agreement that that was not the intent of the hemp legislation at the federal level or here in Ohio, but we did need to do something to protect kids from these products,” he said. “Some of these products are truly illicit and truly dangerous, and everybody, no matter how fervent of an activist on the hemp side of this issue you were, agreed something needed to be done.”
Legislative disagreements had revolved around Ohio businesses that would be negatively impacted by language in previous versions of the bill, Fischer said.
Under the House-passed substitute bill, places where children “walk freely,” like gas stations and grocery stores, would be prohibited from selling intoxicating hemp products, while certain intoxicating hemp retailers, such as a qualifying vape shop, would be “grandfathered in” for licensure.
For a retailer to qualify for a grandfathered-in hemp dispensary license, that retailer must have sold intoxicating hemp products on or before Aug. 30, and the store’s receipts from hemp and intoxicating hemp product sales must have exceeded 80% of its total gross receipts for either the past 12 months or the 2024 calendar year.
“What about those people that have poured their blood, sweat, tears, years of work, potentially millions of dollars into building a business living by the rules that we set out, whether they were adequate or not, they were not breaking the law,” Fischer said. “Those were the people that I was motivated to stand up for, and while this bill doesn’t do everything that I wanted or everything that others want, I believe we have arrived at a reasonable conclusion to allow those people to still stay in business, to grandfather them into this new regulatory regime.”
No one under the age of 21 would be allowed inside these hemp dispensaries, which would be prohibited from selling cigarettes, tobacco, and vape or electronic smoking products under the bill. No more than 400 hemp dispensaries would be allowed in the state, unless those grandfathered in exceed that number.
While the biennial license renewal fee for Ohio’s cannabis dispensaries is $70,000, the two-year renewal license fee for a grandfathered-in hemp dispensary would be $35,000 under Sub. S.B. 56.
Meanwhile, hemp beverages, which the substitute bill defines as “drinkable cannabinoid products,” would be regulated differently. In addition, these products would be classified as low-level DCPs (5 milligrams or less of total THC per serving) or high-level DCPs (5-10 milligrams of total THC per serving). Only one serving per container would be allowed.
Neither low-level nor high-level DCPs would constitute an “intoxicating hemp product,” with DCPs falling under a separate regulatory framework for manufacturers, distributors and retailers. Still, sales to those under 21 would be prohibited.
Ohio retailers with Class C liquor licenses, such as grocery stores that sell alcohol for carryout only, would be allowed to sell high-level DCPs. Meanwhile, Ohio retailers with licenses for on-site consumption, such as restaurants and bars, would be allowed to sell low-level DCPs.
While the substitute bill would allow DCP manufacturers to create higher-dose beverages that contain more than 10 milligrams of THC, they would be restricted to distributing and/or selling those products to out-of-state partners.
Fischer said there were a lot of wins “for us so-called ‘hemp-resentatives,’” in the substitute bill.
“Many of you heard from beverage manufacturers, bars, restaurants, retailers about how popular these products are, but there are also a lot of folks that weren’t yet comfortable stocking these products because of the regulatory uncertainty that is a result of our inability to previously come to an agreement here in Columbus,” he said. “I think this strikes the appropriate tone of a reasonable, fair and pro-business regulatory regime while still maintaining that these products and consumers should be safe.”
While it’s unclear if the Senate will agree to the House’s amended substitute bill or take the legislation to a conference committee for further debate – before possibly sending the bill to DeWine’s desk – the potential outcomes are significant for Ohio stakeholders: cannabis businesses, hemp businesses, consumers, patients and children.
Rep. Jamie Callender, R-Concord, a long-time advocate for cannabis reform in the Buckeye State, acknowledged the legislation “is not perfect” before voting to support the bill.
Callender said a “no” vote on the legislation represents allowing retailers to continue selling high-THC products to children walking home from schools with impunity.
“I imagine everybody in this room can find at least one thing they don’t like in the bill, one thing they think can be improved on,” he said. “You have my commitment. I’ll keep working with everyone to make it better, but I believe we have to act.”
Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
Discover what to know about cannabis and a brain aneurysm—risks, recovery, and medical cautions.
When celebrity Kim Kardashian recently revealed she was diagnosed with a small brain aneurysm—reportedly detected during a routine MRI and attributed by her doctors to stress—her disclosure sparked interest in a condition most people don’t know much about. A brain aneurysm is a bulging or ballooning blood vessel in the brain, which can be life-threatening if it ruptures. With growing interest around cannabis use—both medically and recreationally—it’s worth exploring what to know about cannabis and a brain aneurysm.
RELATED: The Science Behind Cannabis And Happiness
A brain aneurysm (sometimes called an intracranial aneurysm) occurs when a weakened area of a blood vessel in the brain bulges outward. If the aneurysm ruptures, it can lead to a major bleed called a subarachnoid hemorrhage—a medical emergency. Many aneurysms remain small and never rupture, but risk factors include high blood pressure, smoking, genetic predisposition, and possibly vascular stress. Kim Kardashian’s case underlines how even individuals with public profiles and access to healthcare can face this silent risk.

Cannabis—or more precisely its components such as cannabidiol (CBD) and tetrahydrocannabinol (THC)—has been studied for a variety of health issues. For some conditions like chronic pain, certain forms of epilepsy, or spasticity in multiple sclerosis, cannabinoids may offer symptomatic relief. There is emerging evidence medical marijuana can improve quality of life for some patients: reducing pain, improving sleep or mood, and even decreasing reliance on opioids in certain contexts.
In the broad sense, in jurisdictions across the U.S., many patients use it under medical supervision for conditions like migraine, nausea from chemotherapy, or chronic neuropathic pain. “Medical” use does not equate to “safe in all contexts”—especially when other serious medical issues are present.
When it comes to brain aneurysms—particularly after diagnosis or treatment—the research raises caution flags about cannabis use:
- Studies show people who have had an aneurysmal subarachnoid hemorrhage (a burst aneurysm), cannabis users had higher rates of delayed cerebral ischemia (DCI)—a serious complication which can lead to poor outcome. One large study found cannabis users had about a 2.7 times greater risk of DCI compared with non-users.
- Other studies link recreational cannabis use to a higher likelihood of having an aneurysm rupture in the first place—one estimate suggested about an 18 % increased risk.
- Research also suggests cannabis affects vascular tone, cerebral blood flow, mitochondrial function in brain cells, and may contribute to vasospasm (narrowing of blood vessels) or oxidative stress—mechanisms which are particularly concerning in someone with a vulnerable blood vessel wall.
- One review warned even for unruptured aneurysms, if cannabis is used, individuals should be aware they may face worse outcomes should rupture occur.
RELATED: Evidence About Burning Mouth Syndrome And Cannabinoids
If you or someone you know has been diagnosed with a brain aneurysm (ruptured or unruptured), here are some practical steps:
- Talk to your neurologist/neurosurgeon about cannabis use. The research suggests elevated risks in people with aneurysms who use cannabis.
- Avoid assuming “medical use = safe.” Even if you’re using cannabis under a physician’s care, an aneurysm changes the risk profile.
- Focus on established risk-reduction: control blood pressure, stop smoking, manage cholesterol, avoid stimulants. These traditional strategies remain foundational.
- If you have an untreated aneurysm and are considering cannabis for medical reasons, proceed with caution.Ask your medical team about the specific size, location, treatment plan of your aneurysm and whether there are recommended restrictions.
- After an aneurysm rupture or treatment, strongly consider abstaining or closely monitoring any cannabis use. The data indicate increased complication rates in this particular setting.
The public disclosure by Kim Kardashian highlights how common aneurysms may be, but it also reminds us the decision to use cannabis in a medical context should be made carefully. While cannabis offers genuine medical benefits for some conditions, when a brain aneurysm is in the picture—especially one which has ruptured or is being observed—caution is warranted. Speak with a neurologist familiar with cerebrovascular risk, weigh the benefits and the unique risks, and make an informed choice rather than assuming “legal = safe.”
Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
[PRESS RELEASE] – NORWOOD, Mass., Oct. 23, 2025 – MariMed Inc., a leading cannabis consumer packaged goods company and retailer, announced a licensing agreement with Farm 2 Hand LLC, a New York State cannabis license holder, that will introduce the company’s top-selling portfolio of products throughout New York State. Terms of the agreement were not disclosed.
Farm 2 Hand intends to manufacture and distribute a variety of MariMed’s edible products as permitted under New York regulations. Those are initially expected to include Betty’s Eddies fruit chews; Bubby’s Baked baked goods; and InHouse gummies. The products will be produced in a new kitchen that MariMed will design and equip for Farm 2 Hand at Farm 2 Hand’s Bronx production facility.
“Expanding the availability of our brands to the Empire State and its $6 billion total addressable market marks a significant step forward in our plan to own top-selling cannabis brands across the U.S.,” MariMed CEO Jon Levine said. “The addition of New York to our distribution footprint will help drive wholesale revenue, and being in the nation’s top media and influencer market will also help increase national awareness for our brands.”
The company expects its products will be available to New York’s 500-plus dispensaries in 2026, following the build-out of the kitchen and regulatory approval.
Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
Ohio House Passes Cannabis, Hemp Bill Resulting From ‘Venn Diagram From Hell’
What To Know About Cannabis And A Brain Aneurysm
MariMed to Expand Brand Distribution to New York
Time for a Cannabis Reboot: Local Roots, Fair Markets, Real Change
Ohio Health Agency Grants $400,000 To Fund Psychedelics Education And Training For First Responders, Doctors And More
Curio Wellness Acquires 4 Greenlight Dispensaries in Missouri
The best places to be high in Seattle
Colombia’s Bold Offer to Trump: Legal Weed Exports for Peace
Trump DOJ Asks Supreme Court For Delayed Schedule In Case On Marijuana Users’ Gun Rights
Whiskey Company Scales Back Operations, Citing ‘Consumer Shifts’ Toward Marijuana As Alcohol Alternative
Smart Cannabis: The AI Revolution No Operator Can Ignore
New Jersey Gubernatorial Candidates Need To Step Up For Cannabis Consumers (Op-Ed)
Millennials Are Spending Big on Luxury Travel
West Virginia Medical Marijuana Revenue Is Supposed To Support Drug Treatment Programs, But Sits Unspent As Officials Worry About Federal Prohibition
Frequent Marijuana Use Is Tied To Lower Risk Of Liver Disease From Alcohol, New Study Finds
Ohio bill to scale back cannabis legalization passed by House (Newsletter: October 23, 2025)
FDA Weighs Petition On ‘Significant Harm’ Of Marijuana Hair Testing Device’s Positive Results From Secondhand Smoke
Wisconsin Lawmakers Rally for Medical Cannabis Legalization in Committee Hearing
Massachusetts Campaign To Roll Back Marijuana Legalization Law Is ‘On Track’ To Make 2026 Ballot, Spokesperson Says
Village Farms Introduces Industry-First, One-Way Aroma Valve in Cannabis Packaging
Ohio House Passes Bill To Remove Voter-Approved Marijuana Legalization Protections And Restrict Hemp Market
Sorting Robotics Becomes Cannabis Manufacturing’s First True Systems Integrator
Wisconsin Senators Hold Hearing On GOP Leader’s New Medical Marijuana Legalization Bill
Tariffs And Visas Add To The Cannabis Industry’s Misery
Alert: Department of Cannabis Control updates data dashboards with full data for 2023
Connecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!
5 best CBD creams of 2024 by Leafly
Recreational cannabis on ballot for third time in South Dakota
EU initiative begins bid to open access to psychedelic therapies
New Study Analyzes the Effects of THCV, CBD on Weight Loss
Free delta-9 gummies from Bay Smokes
5 best autoflower seed banks of 2024 by Leafly
Discover New York’s dankest cannabis brands [September 2024]
Press Release: CANNRA Calls for Farm Bill to Clarify Existing State Authority to Regulate Hemp Products
May 2024 Leafly HighLight: Pink Runtz strain
5 best THC drinks of 2024 by Leafly
Local medical cannabis dispensary reacts to MSDH pulling Rapid Analytics License – WLBT
6 best CBD gummies of 2024 by Leafly
Curaleaf Start Process Of Getting Their Claws Into The UK’s National Health System – With Former MP (Resigned Today 30/5/24) As The Front Man
Horn Lake denies cannabis dispensary request to allow sale of drug paraphernalia and Sunday sales | News
5 best delta-9 THC gummies of 2024 by Leafly
The Daily Hit: October 2, 2024
Mississippi city official pleads guilty to selling fake CBD products
Nevada CCB to Accept Applications for Cannabis Establishments in White Pine County – “Only one cultivation and one production license will be awarded in White Pine County”
5 best THCA flower of 2024 by Leafly
Weekly Update: Monday, May 13, 2024 including, New Guide for Renewals & May Board meeting application deadline
6 best hemp pre-rolls of 2024 by Leafly
PRESS RELEASE : Justice Department Submits Proposed Regulation to Reschedule Marijuana
Trending
-
California Cannabis Updates1 year agoAlert: Department of Cannabis Control updates data dashboards with full data for 2023
-
Breaking News1 year agoConnecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!
-
best list1 year ago5 best CBD creams of 2024 by Leafly
-
Business1 year agoRecreational cannabis on ballot for third time in South Dakota
-
Business1 year agoEU initiative begins bid to open access to psychedelic therapies
-
cbd1 year agoNew Study Analyzes the Effects of THCV, CBD on Weight Loss
-
Bay Smokes1 year agoFree delta-9 gummies from Bay Smokes
-
autoflower seeds1 year ago5 best autoflower seed banks of 2024 by Leafly


